Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea
· Delayed Price · Currency is KRW 7,230.00
-10.00 (-0.14%)
At close: Mar 6, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 51.28 billion as of March 9, 2026. Its market cap has increased by 23.88% in one year.
Market Cap
51.28B
Enterprise Value
37.81B
Revenue
34.38B
Ranking
n/a
PE Ratio
7.77
Stock Price
7,230.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has increased from 47.59B to 51.28B, an increase of 7.76%. That is a compound annual growth rate of 1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 51.28B | 8.23% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KM Corporation | 44.23B |
| SCL Science | 63.27B |
| MEDYSSEY Co.,Ltd | 41.04B |
| DOBU Inc. | 29.56B |
| Plasmapp | 26.09B |
| Sewoon Medical | 106.50B |
| JW Shinyak | 115.38B |
| OSTEONIC | 123.98B |